Your browser doesn't support javascript.
loading
A comprehensive examination of breast cancer risk loci in African American women.
Feng, Ye; Stram, Daniel O; Rhie, Suhn Kyong; Millikan, Robert C; Ambrosone, Christine B; John, Esther M; Bernstein, Leslie; Zheng, Wei; Olshan, Andrew F; Hu, Jennifer J; Ziegler, Regina G; Nyante, Sarah; Bandera, Elisa V; Ingles, Sue A; Press, Michael F; Deming, Sandra L; Rodriguez-Gil, Jorge L; Palmer, Julie R; Olopade, Olufunmilayo I; Huo, Dezheng; Adebamowo, Clement A; Ogundiran, Temidayo; Chen, Gary K; Stram, Alex; Park, Karen; Rand, Kristin A; Chanock, Stephen J; Le Marchand, Loic; Kolonel, Laurence N; Conti, David V; Easton, Douglas; Henderson, Brian E; Haiman, Christopher A.
Afiliação
  • Feng Y; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Stram DO; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Rhie SK; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Millikan RC; Department of Epidemiology, Gillings School of Global Public Health, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • John EM; Cancer Prevention Institute of California, Fremont, CA, USA Division of Epidemiology, Department of Health Research & Policy, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Bernstein L; Division of Cancer Etiology, Department of Population Science, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Olshan AF; Department of Epidemiology, Gillings School of Global Public Health, and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Hu JJ; Sylvester Comprehensive Cancer Center and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Ziegler RG; Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics and.
  • Nyante S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Bandera EV; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Ingles SA; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Press MF; Department of Pathology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Deming SL; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Rodriguez-Gil JL; Sylvester Comprehensive Cancer Center and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Palmer JR; Slone Epidemiology Center at Boston University, Boston, MA, USA.
  • Olopade OI; Center for Clinical Cancer Genetics & Global Health, Department of Medicine and.
  • Huo D; Department of Health Studies, University of Chicago, Chicago, IL, USA.
  • Adebamowo CA; Department of Epidemiology & Preventive Medicine, University of Maryland, Baltimore, MD, USA.
  • Ogundiran T; Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Chen GK; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Stram A; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Park K; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Rand KA; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Chanock SJ; Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics and.
  • Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Kolonel LN; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Conti DV; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Henderson BE; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and.
  • Haiman CA; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center and haiman@usc.edu.
Hum Mol Genet ; 23(20): 5518-26, 2014 Oct 15.
Article em En | MEDLINE | ID: mdl-24852375
ABSTRACT
Genome-wide association studies have identified 73 breast cancer risk variants mainly in European populations. Given considerable differences in linkage disequilibrium structure between populations of European and African ancestry, the known risk variants may not be informative for risk in African ancestry populations. In a previous fine-mapping investigation of 19 breast cancer loci, we were able to identify SNPs in four regions that better captured risk associations in African American women. In this study of breast cancer in African American women (3016 cases, 2745 controls), we tested an additional 54 novel breast cancer risk variants. Thirty-eight variants (70%) were found to have an association with breast cancer in the same direction as previously reported, with eight (15%) replicating at P < 0.05. Through fine-mapping, in three regions (1q32, 3p24, 10q25), we identified variants that better captured associations with overall breast cancer or estrogen receptor positive disease. We also observed suggestive associations with variants (at P < 5 × 10(-6)) in three separate regions (6q25, 14q13, 22q12) that may represent novel risk variants. Directional consistency of association observed for ∼65-70% of currently known genetic variants for breast cancer in women of African ancestry implies a shared functional common variant at most loci. To validate and enhance the spectrum of alleles that define associations at the known breast cancer risk loci, as well as genome-wide, will require even larger collaborative efforts in women of African ancestry.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Neoplasias da Mama / Predisposição Genética para Doença Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Neoplasias da Mama / Predisposição Genética para Doença Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article